Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology GroupYousif Matloub, Paul S. Gaynon, Bruce Bostrom et al.|Blood|2011Cited by 148
Donor Cell–Derived Leukemias/Myelodysplastic Neoplasms in Allogeneic Hematopoietic Stem Cell Transplant RecipientsEndi Wang, Patrick J. Buckley, Siby Sebastian et al.|American Journal of Clinical Pathology|2011Cited by 64
Escalating Dose Intravenous Methotrexate without Leucovorin Rescue during Interim Maintenance Is Superior to Oral Methotrexate for Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): Children’s Oncology Group Study 1991Yousif Matloub, Paul S. Gaynon, Bruce Bostrom et al.|Blood|2008Cited by 17